Revenue | 13.33M |
Cost of sales | 11.06M |
Gross margin | 2.27M |
Operating expenses: | |
Research and product development | 957K |
Sales and marketing | 463K |
General and administrative | 2.79M |
Total operating expenses | 4.21M |
Operating loss | -1.94M |
Foreign exchange gain | 11K |
Interest and other income | 145K |
Interest and other expense | -874K |
Net loss | -2.66M |
Dividends on preferred stock | 302K |
Net loss available to common stockholders, basic and diluted | |
Other comprehensive loss: | |
Net loss | -2.66M |
Change in foreign currency translation adjustments | -8K |
Comprehensive loss | -2.67M |
Net loss per share available to common stockholders, basic and diluted (in Dollars per share) | -0.02 |
Shares used in computing net loss per share available to common stockholders, basic and diluted (in Shares) | -325.97M |